TrialSchizophrenia bulletin2022

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms.

Erica Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.